Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Tu Fu Ling Tablets in rheumatoid arthritis
ChiCTR-TRC-11001755Phase 2Completed
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Oct 2007
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Tu Fu Ling Tablets in rheumatoid arthritis (RA) (3 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: American College of Rheumatology 20% response criteria and Adverse events rate. Started Oct 2007; status: completed.
02
Drugs
Tu Fu Ling Tablets
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR-TRC-11001755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001755.